A UCL-developed app that provides speech therapy for people with the language disorder aphasia has been found to significantly improve their ability to talk.
Feb 21, 2024
0
49
Texas A&M School of Veterinary Medicine & Biomedical Sciences (VMBS), Baylor College of Medicine, and Texas Children's Hospital researchers have discovered that meningiomas—the most common type of brain tumor in humans ...
Feb 21, 2024
0
27
Imperial researchers have used artificial intelligence (AI) to extract information about the chemical makeup of lung tumors from medical scans. For the first time, they have demonstrated how combining medical imaging with ...
Feb 21, 2024
0
18
Researchers have revealed the mechanism of a drug shown to be effective in treating certain types of cancer, which targets a protein modification silencing the expression of multiple tumor suppressor genes. They also demonstrated ...
Feb 21, 2024
0
20
A UC Davis Health study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumor burden and extended the survival of mice with liver cancer. The study, published ...
Feb 21, 2024
0
19
Researchers at Columbia University have found a molecule that is responsible for arousing dormant cells from breast cancer and nudging them to create metastases. Silencing this molecule, called Malat1, in mice with breast ...
Feb 19, 2024
0
44
A new study led by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) has identified a crucial factor that can drive tumor cells to spread to the liver. The work, which is published in the current issue ...
Feb 19, 2024
0
33
An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer with few effective treatment options, according to results from a clinical trial ...
Feb 15, 2024
0
34
Immunotherapy is already improving treatment options for many cancer types, but research groups keep exploring ways to boost the body's immune response against the tumor.
Feb 14, 2024
0
20
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel Cancer Center.
Feb 14, 2024
0
19
